--- title: "AEQUITA PHARMACY Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search AEQUITA PHARMACY recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/aequita-pharmacy/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # AEQUITA PHARMACY recall records **13** reported ongoing 13 records in this archive. Latest source date Jul 18, 2025. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Jul 18, 2025 FDA drug enforcement ### [Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, Multi Dose Vial, Refrigerate, Do not freeze, Aequita P...](https://isitonrecall.com/recall/fda-drug-d-0553-2025-semaglutide-cyanocobalamin-0-22-mg-0-25mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutane/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe)...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0553-2025%22) Jul 18, 2025 FDA drug enforcement ### [Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Ph...](https://isitonrecall.com/recall/fda-drug-d-0554-2025-tirzepatide-niacinamide-2-2-mg-1-0mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutaneously/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subc...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0554-2025%22) Jul 18, 2025 FDA drug enforcement ### [Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita P...](https://isitonrecall.com/recall/fda-drug-d-0555-2025-tirzepatide-niacinamide-4-4-mg-1-0mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutaneously/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subc...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0555-2025%22) Jul 18, 2025 FDA drug enforcement ### [Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita P...](https://isitonrecall.com/recall/fda-drug-d-0556-2025-tirzepatide-niacinamide-6-6-mg-1-0mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutaneously/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subc...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0556-2025%22) Jul 18, 2025 FDA drug enforcement ### [Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita P...](https://isitonrecall.com/recall/fda-drug-d-0557-2025-tirzepatide-niacinamide-8-8-mg-1-0mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutaneously/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subc...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0557-2025%22) Jul 18, 2025 FDA drug enforcement ### [Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita...](https://isitonrecall.com/recall/fda-drug-d-0558-2025-tirzepatide-niacinamide-11-24-mg-1-0mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutaneous/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) su...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0558-2025%22) Jul 18, 2025 FDA drug enforcement ### [Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita ...](https://isitonrecall.com/recall/fda-drug-d-0559-2025-tirzepatide-niacinamide-13-2-mg-1-0mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutaneousl/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) sub...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0559-2025%22) Jul 18, 2025 FDA drug enforcement ### [Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 3 x 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequ...](https://isitonrecall.com/recall/fda-drug-d-0560-2025-tirzepatide-niacinamide-16-6-mg-1-0mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutaneousl/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) sub...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0560-2025%22) Jul 18, 2025 FDA drug enforcement ### [Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequ...](https://isitonrecall.com/recall/fda-drug-d-0561-2025-semaglutide-cyanocobalamin-0-44-mg-0-25mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutane/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0561-2025%22) Jul 18, 2025 FDA drug enforcement ### [Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequ...](https://isitonrecall.com/recall/fda-drug-d-0562-2025-semaglutide-cyanocobalamin-0-88-mg-0-25mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutane/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0562-2025%22) Jul 18, 2025 FDA drug enforcement ### [Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequit...](https://isitonrecall.com/recall/fda-drug-d-0563-2025-semaglutide-cyanocobalamin-1-5-mg-0-25mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutaneo/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) s...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0563-2025%22) Jul 18, 2025 FDA drug enforcement ### [Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate,...](https://isitonrecall.com/recall/fda-drug-d-0564-2025-semaglutide-cyanocobalamin-injection-solution-2-21-mg-0-25mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-o/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0564-2025%22) Jul 18, 2025 FDA drug enforcement ### [Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequ...](https://isitonrecall.com/recall/fda-drug-d-0565-2025-semaglutide-cyanocobalamin-2-67-mg-0-25mg-0-5-ml-inj-sol-inject-0-5-ml-50-units-on-syringe-subcutane/) Lack of Processing Controls. Class II Reported ongoing Distribution: MA [Official source for Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe)...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0565-2025%22) ## Reasons in these listed records - Lack of Processing Controls. These examples come from this result page and are not a ranking of every recall reason. ## Checking AEQUITA PHARMACY ### Is there a recall on aequita pharmacy right now? This archive contains 13 records, including 13 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search AEQUITA PHARMACY](https://isitonrecall.com/check/?q=AEQUITA%20PHARMACY) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)